Design and synthesis of a system for enediyne formation by anthraquinone reductive activationMYERS, A. G; DRAGOVICH, P. S.Journal of the American Chemical Society. 1992, Vol 114, Num 14, pp 5859-5860, issn 0002-7863Article

A reaction cascade leading to 1,6-didehydro[10]annulene → 1,5-dehydronaphthalene cyclization initiated by thiol additionMYERS, A. G; DRAGOVICH, P. S.Journal of the American Chemical Society. 1993, Vol 115, Num 15, pp 7021-7022, issn 0002-7863Article

Design and dynamics of a chemically triggered reaction cascade leading to biradical formation at subambient temperatureMYERS, A. G; DRAGOVICH, P. S.Journal of the American Chemical Society. 1989, Vol 111, Num 25, pp 9130-9132, issn 0002-7863Article

A regioselective synthesis of pyrroles via the coupling of α,β-unsaturated imines with esters or N,N-dimethylformamide promoted by NbCl₃(DME)ROSKAMP, E. J; DRAGOVICH, P. S; HARTUNG, J. B. JR et al.Journal of organic chemistry. 1989, Vol 54, Num 20, pp 4736-4737, issn 0022-3263Article

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsDRAGOVICH, P. S; RU ZHOU; MEADOR, J. W et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 1, pp 45-48, issn 0960-894XArticle

Spectroscopic and crystallographic characterization of (σ²-terpyridyl)Re(CO)₃Cl. 2D-NMR evidence for a linkage isomerization reactionCIVITELLO, E. R; DRAGOVICH, P. S; KARPISHIN, T. B et al.Inorganic chemistry (Print). 1993, Vol 32, Num 2, pp 237-241, issn 0020-1669Article

Structure-based design of novel, urea-containing FKBP12 inhibitorsDRAGOVICH, P. S; BARKER, J. E; PELLETIER, L. A. K et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 9, pp 1872-1884, issn 0022-2623Article

Studies on the thermal generation and reactivity of a class of (σ,π)-1,4-biradicalsMYERS, A. G; DRAGOVICH, P. S; KUO, E. Y et al.Journal of the American Chemical Society. 1992, Vol 114, Num 24, pp 9369-9386, issn 0002-7863Article

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorZALMAN, L. S; BROTHERS, M. A; DRAGOVICH, P. S et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1236-1241, issn 0066-4804Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; TIKHE, J et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2819-2834, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P₁ lactam moieties as L-glutamine replacementsDRAGOVICH, P. S; PRINS, T. J; BURKE, B. J et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1213-1224, issn 0022-2623Article

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteasePATICK, A. K; BINFORD, S. L; FUHRMAN, S. A et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 10, pp 2444-2450, issn 0066-4804Article

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsDRAGOVICH, P. S; WEBBER, S. E; BROWN, E. L et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 15, pp 2189-2194, issn 0960-894XArticle

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimeticsDRAGOVICH, P. S; PRINS, T. J; ZHOU, R et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1203-1212, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; LITTLEFIELD, E. S et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2806-2818, issn 0022-2623Article